Dental Tribune Hispanic and Latin American Edition

DENTAL TRIBUNE Hispanic & Latin America Conclusión Atodoslosefectos,lomásrazonablees hacer un seguimiento exhaustivo de la patología y evitar su propagación. Es evidente que una pequeña lesión será mucho más fácil de tratar que otra que se haya extendido. Esta pauta es fundamental en el caso de la osteonecrosis. La aplicación ambulatoria de ozono podría ser una alternativa viable para tratar la osteonecrosis, de fácil aplicación, bajo costo y muy poco agresiva. Sin embargo, la resolución de un solo caso clínico no es significativo y deberemos esperar a otros estudios para contar con un protocolo clínico de esta terapia. Referencias DiGiovanni C.W. et al. Osteonecrosis in1. the foot. J Am Acad Orthop Surg 2007; 15(4): 208-207. ISSN 1067-151X. Y. C. Chao et al. Investigation of2. alcohol metabolizing enzyme genes in Chinese alcoholics with avascular necrosis of hip joint, pancreatitis and cirrhosis of the liver. Alcohol Alcohol 2003: 431-436. ISSN 0735-0414. Juery P. Avascular necrosis after a3. steroid injection 2007: 814. ISSN 0820- 3946. PMC 1808528. Zhang L. D. «Distribution of lesions in4. the head and neck of the humerus and the femur in dysbaric osteonecrosis» (1990). ISSN 0093-5387. Lafforgue P. Pathophysiology and5. natural history of avascular necrosis of bone. Joint Bone Spine 2007: 500-5007. ISSN 1297-319X. Laroche M. Intraosseous circulation6. from physiology to disease. Joint Bone Spine 2002: 262-269. ISSN 1297-319X. Marti-Carvajal A, Dunlop R, Agreda-7. Perez, L. Treatment for avascular necrosis of bone in people with sickle cell disease 2004. The Merck Manual (18° edición). pp.8. 311. Day SM, Ostrum RF, Chao EYS,9. Rubin CT, Aro HT, Einhorn TA. Bone Injury, Regeneration and Repair. In: Orthopaedic Basic Science, 2nd Ed, Edited by Am Acad Orthop Surg 2000: 371-399. ISBN 0-89203-177-8. OCLC 42969533 Hoefert S, Eufinger H. Relevance10. of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw. J Oral Maxillofac Surg. 2011 Feb;69(2):362-80. Epub 2010 Dec 3. Rogers SN, Hung J, Barber AJ, Lowe11. D. A survey of consultant members of the British Association of Oral and Maxillofacial Surgeons regarding bisphosphonate-induced osteonecrosis of the jaws. Br J Oral Maxillofac Surg. 2009 Dec;47(8):598-601. Epub 2009 Sep 12. Williamson RA. Surgical management12. of bisphosphonate induced osteonecrosis of the jaws. Int J Oral Maxillofac Surg. 2010 Mar;39(3):251-5. Epub 2009 Dec 16. Antonini F, Pereira CC, Parente13. EV, Azambuja FG. Management of osteonecrosis of the jaws in patients with history of bisphosphonates therapy. J Craniofac Surg. 2010 Nov;21(6):1962-6. Yamazaki Y, Kitagawa Y, Hata H, Abe14. T, Murai C, Shiga T, Tamaki N. Clin Use of FDG PET to evaluate hyperbaric oxygen therapy for bisphosphonate- related osteonecrosis of the jaw. Nucl Med. 2010 Aug;35(8):590-1. No abstract available. Luomanen M, Alaluusua S. Treatment15. of bisphosphonate-induced osteonecrosis of the jaws with Nd:YAG laser biostimulation. Lasers Med Sci. 2011 May 20. Romeo U, Galanakis A, Marias C,16. Vecchio AD, Tenore G, Palaia G, Vescovi P, Polimeni A. Observation of pain control in patients with bisphosphonate-induced osteonecrosis using low level laser therapy: preliminary results. Photomed Laser Surg. 2011 Jul;29(7):447-52. Epub 2011 Jan 16. Agrillo A, Sassano P, Rinna C, Priore P,17. Iannetti G. Ozone therapy in extractive surgery on patients treated with bisphosphonates. J Craniofac Surg. 2007 Sep;18(5):1068-70. Petrucci MT, Gallucci C, Agrillo18. A, Mustazza MC, Foà R. Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients. Haematologica. 2007 Sep;92(9):1289-90. Agrillo A, Petrucci MT, Tedaldi M,19. Mustazza MC, Marino SM, Gallucci C, Iannetti G. New therapeutic protocol in the treatment of avascular necrosis of the jaws. J Craniofac Surg. 2006 Nov;17(6):1080-3. Agrillo A, Ungari C, Filiaci F,20. Priore P, Iannetti G. Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis. J Craniofac Surg. 2007 Sep;18(5):1071-5. Ripamonti CI, Cislaghi E, Mariani L,21. Maniezzo M. Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: Preliminary results of a phase I-II study. Oral Oncol. 2011 Mar;47(3):185-90. Caso clínico 27 Fig. 12 Fig. 13